| 摘要 |
A method for inhibiting platelet aggregation in a patient in need thereof, comprising administering to the patient, for a period of time of greater than 24 hours, a glycoprotein IIb/IIIa receptor antagonist in an amount sufficient to achieve a steady state plasma level concentration which provides at least about 70 % inhibition of fibrinogen binding to the IIb/IIIa receptor. |
